GeneXpert MTB/RIF检查确诊的结核性心包积液1例合并文献复习

doi:10.16150/j.1671-2870.2023.03.14

摘要/Abstract

摘要：

本文报道1例经GeneXpert MTB/RIF（结核分枝杆菌rpoB基因和突变检测）检查证实的结核性心包积液患者，并结合相关文献病例进行分析探讨。本例患者在疾病初期，常规抗感染无效，病原菌寻找无果，并排除了肿瘤以及其他病因，临床考虑为结核性心包积液，但心包积液反复检测抗酸杆菌为阴性。对患者心包积液进行GeneXpert MTB/RIF检查，获得阳性（极低）结果。遂予患者抗结核治疗，2周后患者心包积液降至少量，症状明显好转；3个月后，心包积液降至极少量，症状消失。该病例的诊治过程提示，临床诊断结核性心包积液时，除行传统的抗酸杆菌涂片观察和分枝杆菌培养，还要积极在早期应用其他检查方法，如测定心包积液腺苷脱氨酶(adenosine deaminase，ADA)、心包积液GeneXpert MTB/RIFF检查以及血液结核感染γ干扰素释放试验（interferon-gamma release assay，IGRA)。

关键词: 结核, 心包积液, GeneXpert MTB/RIF

Abstract:

This paper reported a case of tuberculous pericardial effusion which was confirmed by GeneXpert MTB/RIF (Mycobacterium tuberculosis rpoB gene and mutation detection). During the early stage of the diagnosis, the routine anti-infection was ineffective, the pathogenic bacteria was not founded in the case, and tumor or other causes were excluded. The clinical diagnosis was considered as tuberculous pericardial effusion, while multiple tests for acid-fast bacilli was negative. The patient’s pericardial effusion was used to perform GeneXpert MTB/RIF test, and positive (very low dose) result was obtained. Through anti-tuberculous treatment, the pericardial effusion of the patient decreased to a small amount and the symptoms improved significantly after 2 weeks. And 3 months later, the symptoms disappeared. The diagnosis and treatment of the patient suggested that multiple methods should be actively applied during the early stage of clinical diagnosing tuberculous pericardial effusion. Beside traditional acid-fast bacillus smear and mycobacterium culture, the adenosine deaminase (ADA) and GeneXpert MTB/RIFF tests for pericardial effusion and interferon-gamma release assay (IGRA) for blood should be considered.

Key words: Tuberculous, Pericardial effusion, GeneXpert MTB/RIF

中图分类号:

R52
R542.12

彭荣, 李牧, 马阔, 龚倩. GeneXpert MTB/RIF检查确诊的结核性心包积液1例合并文献复习[J]. 诊断学理论与实践, 2023, 22(03): 300-302.

PENG Rong, LI Mu, MA Kuo, GONG Qian. A case of tuberculous pericardial effusion confirmed by GeneXpert MTB/RIF combined with literature review[J]. Journal of Diagnostics Concepts & Practice, 2023, 22(03): 300-302.

图/表 1

参考文献 18

[1]	CHANG S A. Tuberculous and Infectious Pericarditis[J]. Cardiol Clin, 2017, 35(4):615-622. doi: 10.1016/j.ccl.2017.07.013 URL
[2]	庞伦祥. 心包积液381例病因及误诊分析[J]. 重庆医学, 2011, 40(7):670-671.
	PANG L X. Analysis of causes of pericardial effusion and misdiagnosis in 381 cases[J]. Chongqing Med, 2011, 40(7):670-671.
[3]	SYED F F, MAYOSI B M. A modern approach to tuberculous pericarditis[J]. Prog Cardiovasc Dis, 2007, 50(3):218-236. doi: 10.1016/j.pcad.2007.03.002 pmid: 17976506
[4]	梁晨, 于佳佳, 唐神结. 世界卫生组织《全球结核病报告2022》解读[J]. 诊断学理论与实践, 2023, 22(1):21-30.
	LIANG C, YU J J, TANG S J. Interpretation of the Global Tuberculosis Report 2022 by World Health Organization[J]. J Diagn Concepts Pract, 2023, 2(1):21-30.
[5]	王彦斌, 刘纯纯, 郝文嘉, 等. 结核性心包炎合并心包结核瘤一例[J]. 中国防痨杂志, 2023, 45(2):218-221.
	WANG Y B, LIU C C, HAO W J, et al. A case of tuberculous pericarditis complicated with pericardial tuberculoma[J]. Chin J Antituberc, 2023, 45(2)218-221.
[6]	吴艳华, 李霞. 结核性心包积液实验室诊断手段评价[J]. 齐鲁医学杂志, 2014, 29(5):442-444,447.
	WU Y H, LI X. Evaluation of laboratory diagnostics of tuberculous pericardial effusion[J]. Med J Qilu, 2014, 29(5):442-444,447.
[7]	WANG S, WANG J, LIU J, et al. A case report and review of literature: Tuberculous pericarditis with pericardial effusion as the only clinical manifestation[J]. Front Cardiovasc Med, 2022, 9:1020672. doi: 10.3389/fcvm.2022.1020672 URL
[8]	吴殷, 张培元. 结核性心包炎诊断及治疗进展[J]. 中国防痨杂志, 2002, 24(1):37-40.
	WU Y, ZHANG P Y. Recent advance in tuberculosis pericarditic diagnosis and treatment[J]. Chin J Antituberc, 2002, 24(1):37-40.
[9]	BAQI A, AHMED I. Pericardiocentesis indications and complications: a retrospective observational study in a tertiary care hospital in Karachi, Pakistan[J]. Cureus, 2020, 12(8):e10102.
[10]	余鹏, 曾文飞, 林凯玲, 等. 大量心包积液病因影响因素的回顾性分析[J]. 中国心血管病研究, 2020, 18(12):1082-1087.
	YU P, ZENG W F, LIN K L, et al. Retrospective analysis of the etiological factors with large pericardial effusion[J]. Chin J Cardiovasc Res, 2020, 18(12):1082-1087.
[11]	王永生, 周航, 刘蔺, 等. 结核感染T细胞斑点试验在结核性心包炎诊断中的应用[J]. 四川医学, 2013, 34(2):159-160.
	WANG Y S, ZHOU H, LIU L, et al. Diagnositic value of interferon-gamma release assay T-Spot TB for tuberculous pericarditis a prospectiv cohort study[J]. Sichuan Med J, 2013, 34(2):159-160.
[12]	REUTER H, BURGESS L, VAN VUUREN W, et al. Diagnosing tuberculous pericarditis[J]. QJM, 2006, 99(12):827-839. doi: 10.1093/qjmed/hcl123 URL
[13]	田野, 梁德维, 夏颖肃, 等. 聚合酶链反应快速诊断结核性心包炎[J]. 实用心脑肺血管病杂志, 1995, (2):3-5.
	TIAN Y, LIANG D W, XIA Y S, et al. Rapid diagnosis of tuberculous pericarditis by polymerase chain reaction[J]. Pract J Card Cereb Pneumal Vasc Dis, 1995,(2):3-5.
[14]	BOEHME C C, NABETA P, HILLEMANN D, et al. Rapid molecular detection of tuberculosis and rifampin resistance[J]. N Engl J Med, 2010, 363(11):1005-1015. doi: 10.1056/NEJMoa0907847 URL
[15]	彭荣, 王芳, 曲浩. GeneXpert MTB技术在肺外结核诊断中的应用进展[J]. 检验医学与临床, 2019, 16(17):2560-2562.
	PENG R, WANG F, QU H. Application of GeneXpert MTB technique in the diagnosis of extrapulmonary tuberculosis[J]. Lab Med Clin, 2019, 16(17):2560-2562.
[16]	SAEED M, AHMAD M, IRAM S, et al. GeneXpert technology. A breakthrough for the diagnosis of tuberculous pericarditis and pleuritis in less than 2 hours[J]. Saudi Med J, 2017, 38(7):699-705. doi: 10.15537/smj.2017.7.17694 pmid: 28674714
[17]	NAICKER K, NTSEKHE M. Tuberculous pericardial disease: a focused update on diagnosis, therapy and prevention of complications[J]. Cardiovasc Diagn Ther, 2020, 10(2):289-295. doi: 10.21037/cdt URL
[18]	付芬芬, 程艳超, 徐发林, 等. 宏基因组学二代测序技术诊断先天性结核病1例[J]. 安徽医学, 2023, 44(8):1008-1009.
	FU F F, CHENG Y C, XU F L, et al. Metagenomics se-cond generation sequencing technology for diagnosis of congenital tuberculosis: a case report[J]. Anhui Med, 2023, 44(8):1008-1009.